LXEO 8-K 2026-09-22

Lexeo Therapeutics, Inc. (LXEO) 8-K dated 2026-09-22 — accession 0001193125-26-397221. This URL is the filing, not the LXEO hub.

Lexeo Therapeutics, Inc. (LXEO) is a biotechnology company listed on US.

Lexeo Therapeutics, Inc. filed a 8-K on 2026-09-22. Accession 0001193125-26-397221.

Cached items: 1.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LXEO revenue for 2022-12-31 was $654.0K. Net income was $59.3M. LXEO currently screens at market cap $147.7M.

Not investment advice. The LXEO SEC hub lists recent forms. The stock page is the research view.